IDEAYA Biosciences, Inc. (IDYA) Operating income 2017–2025
IDEAYA Biosciences, Inc. (IDYA) annual operating income history from SEC filings — each fiscal year as reported.
-$159.3MFY2025 · since FY2017: -$14.4M → -$159.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$159.3M | +51.3% |
| FY2024 | -$327.0M | -143.2% |
| FY2023 | -$134.4M | -115.1% |
| FY2022 | -$62.5M | -24.3% |
| FY2021 | -$50.3M | -42.2% |
| FY2020 | -$35.3M | +20.2% |
| FY2019 | -$44.3M | -21.6% |
| FY2018 | -$36.4M | -152.2% |
| FY2017 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating marginIDYA Operating cash flowIDYA Free cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →